Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver G Cameron

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Essential Psychopharmacology|September 23, 2006
Anxious-depressive comorbidity: effects on HPA axis and CNS noradrenergic functionsOliver G Cameron
Neuroimage|May 19, 2009
Visceral brain-body information transferOliver G Cameron
Critical Care Clinics|October 30, 2007
Delirium, depression, and other psychosocial and neurobehavioral issues in cardiovascular diseaseOliver G Cameron
Psychosomatic Medicine|December 4, 2002
Regional brain activation due to pharmacologically induced adrenergic interoceptive stimulation in humansOliver G Cameron, Satoshi Minoshima
Biological Psychiatry|December 4, 2004
Anxious and depressive disorders and their comorbidity: effect on central nervous system noradrenergic functionOliver G Cameron, James L Abelson, Elizabeth A Young
Psychoneuroendocrinology|May 18, 2005
Interaction of brain noradrenergic system and the hypothalamic-pituitary-adrenal (HPA) axis in manElizabeth A Young, James L Abelson, Oliver G Cameron
Biological Psychiatry|July 3, 2004
Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depressionElizabeth A Young, James L Abelson, Oliver G Cameron
Journal of Clinical Psychopharmacology|January 12, 2005
Relative rectal bioavailability of fluoxetine in normal volunteersChristian J Teter, K Luan Phan, Oliver G Cameron, et al.
Addictive Behaviors|February 19, 2005
Validation of retrospective reports of early experiences with smokingOvide F Pomerleau, Cynthia S Pomerleau, Ann M Mehringer, et al.
Human Psychopharmacology|September 21, 2004
Depression, smoking abstinence and HPA function in women smokersOvide F Pomerleau, Cynthia S Pomerleau, Sandy M Snedecor, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Essential Psychopharmacology|September 23, 2006
Anxious-depressive comorbidity: effects on HPA axis and CNS noradrenergic functionsOliver G Cameron
Neuroimage|May 19, 2009
Visceral brain-body information transferOliver G Cameron
Critical Care Clinics|October 30, 2007
Delirium, depression, and other psychosocial and neurobehavioral issues in cardiovascular diseaseOliver G Cameron
Psychosomatic Medicine|December 4, 2002
Regional brain activation due to pharmacologically induced adrenergic interoceptive stimulation in humansOliver G Cameron, Satoshi Minoshima
Biological Psychiatry|December 4, 2004
Anxious and depressive disorders and their comorbidity: effect on central nervous system noradrenergic functionOliver G Cameron, James L Abelson, Elizabeth A Young
Psychoneuroendocrinology|May 18, 2005
Interaction of brain noradrenergic system and the hypothalamic-pituitary-adrenal (HPA) axis in manElizabeth A Young, James L Abelson, Oliver G Cameron
Biological Psychiatry|July 3, 2004
Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depressionElizabeth A Young, James L Abelson, Oliver G Cameron
Journal of Clinical Psychopharmacology|January 12, 2005
Relative rectal bioavailability of fluoxetine in normal volunteersChristian J Teter, K Luan Phan, Oliver G Cameron, et al.
Addictive Behaviors|February 19, 2005
Validation of retrospective reports of early experiences with smokingOvide F Pomerleau, Cynthia S Pomerleau, Ann M Mehringer, et al.
Human Psychopharmacology|September 21, 2004
Depression, smoking abstinence and HPA function in women smokersOvide F Pomerleau, Cynthia S Pomerleau, Sandy M Snedecor, et al.
Pageof 2